Treatment of Residual, Non-infiltrating Bladder Cancer with Bacillus Calmette-guerin

No AccessJournal of Urology1 May 1981Treatment of Residual, Non-infiltrating Bladder Cancer with Bacillus Calmette-guerin A. Morales, P. Ottenhof, and L. Emerson A. MoralesA. Morales , P. OttenhofP. Ottenhof , and L. EmersonL. Emerson View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)55150-2AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Systemic and intracavitary administrations of bacillus Calmette-Guerin were used to treat a group of patients with incompletely resected transitional cell carcinoma of the bladder. The treatment induced tumor regression in 59 per cent of the patients. This trial confirms previous reports indicating that non-specific active immunotherapy is useful in the prevention of superficial recurrences as well as in the treatment of residual tumors that have not infiltrated. © 1981 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byNepple K, Lightfoot A, Rosevear H, O'Donnell M and Lamm D (2010) Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder CancerJournal of Urology, VOL. 184, NO. 5, (1915-1919), Online publication date: 1-Nov-2010.O'DONNELL M, KROHN J and DeWOLF W (2018) SALVAGE INTRAVESICAL THERAPY WITH INTERFERON-α2B PLUS LOW DOSE BACILLUS CALMETTE-GUERIN IS EFFECTIVE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER IN WHOM BACILLUS CALMETTE-GUERIN ALONE PREVIOUSLY FAILEDJournal of Urology, VOL. 166, NO. 4, (1300-1305), Online publication date: 1-Oct-2001.Levi D'Ancona C, Rodrigues Netto N, Almeida Claro J and Ikari O (2018) Oral or Intravesical Bacillus Calmette-Guerin Immunoprophylaxis in Bladder CarcinomaJournal of Urology, VOL. 145, NO. 3, (498-501), Online publication date: 1-Mar-1991.Marsh C, Torrey R, Woolley J, Barker G and Lau B (2018) Superiority of Intravesical Immunotherapy with Corynebacterium Parvum and Allium Sativum in Control of Murine Bladder CancerJournal of Urology, VOL. 137, NO. 2, (359-362), Online publication date: 1-Feb-1987.Lau B, Woolley J, Marsh C, Barker G, Koobs D and Torrey R (2018) Superiority of Intralesional Immunotherapy with Corynebacterium Parvum and Allium Sativum in Control of Murine Transitional Cell CarcinomaJournal of Urology, VOL. 136, NO. 3, (701-705), Online publication date: 1-Sep-1986.Droller M (2018) Bacillus Calmette-Guerin in the Management of Bladder CancerJournal of Urology, VOL. 135, NO. 2, (331-333), Online publication date: 1-Feb-1986.Schellhammer P, Ladaga L and Fillion M (2018) Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 135, NO. 2, (261-264), Online publication date: 1-Feb-1986.Kelley D, Ratliff T, Catalona W, Shapiro A, Lage J, Bauer W, Haaff E and Dresner S (2018) Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment ResultsJournal of Urology, VOL. 134, NO. 1, (48-53), Online publication date: 1-Jul-1985.deKernion J, Huang M, Lindner A, Smith R and Kaufman J (2018) The Management of Superficial Bladder Tumors and Carcinoma in situ with Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. 133, NO. 4, (598-600), Online publication date: 1-Apr-1985.Droller M (2018) Editorial CommentsJournal of Urology, VOL. 132, NO. 4, (676-677), Online publication date: 1-Oct-1984.Lamm D (2018) Editorial CommentsJournal of Urology, VOL. 132, NO. 4, (676-676), Online publication date: 1-Oct-1984.Netto N and Lemos G (2018) Bacillus Calmette-Guerin Immunotherapy of Infiltrating Bladder CancerJournal of Urology, VOL. 132, NO. 4, (675-676), Online publication date: 1-Oct-1984.Morales A (2018) Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder CancerJournal of Urology, VOL. 132, NO. 3, (457-459), Online publication date: 1-Sep-1984.Shapiro A, Ratliff T, Oakley D and Catalona W (2018) Comparison of the Efficacy of Intravesical Bacillus Calmette-Guérin with Thiotepa, Mitomycin C, Poly I:C/Poly-L-Lysine and Cis Platinum in Murine Bladder CancerJournal of Urology, VOL. 131, NO. 1, (139-142), Online publication date: 1-Jan-1984.Mcroberts J (2018) Editorial CommentJournal of Urology, VOL. 129, NO. 1, (31-32), Online publication date: 1-Jan-1983.Adolphs H and Bastian H (2018) Chemoimmune Prophylaxis of Superficial Bladder CancerJournal of Urology, VOL. 129, NO. 1, (29-31), Online publication date: 1-Jan-1983.Shapiro A, Kadmon D, Catalona W and Ratliff T (2018) Immunotherapy of Superficial Bladder CancerJournal of Urology, VOL. 128, NO. 5, (891-894), Online publication date: 1-Nov-1982. Volume 125 Issue 5 May 1981 Page: 649-651 Advertisement Copyright & Permissions© 1981 by The American Urological Association Education and Research, Inc.Metrics Author Information A. Morales More articles by this author P. Ottenhof More articles by this author L. Emerson More articles by this author Expand All Advertisement PDF downloadLoading ...